Infect Immun 1999, 67:546–553.PubMed 13. Clermont O, Bonacorsi S, Bingen E: Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000, 66:4555–4558.PubMedCrossRef

14. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP: Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. PCI-32765 order J Antimicrob Chemother 2008, 61:273–281.PubMedCrossRef 15. Rogers BA, Sidjabat HE, Paterson DL: Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother 2011, 66:1–14.PubMedCrossRef 16. Mamlouk K, Boutiba-Ben Boubaker I, Gautier V, Vimont S, Picard B: Emergence and outbreaks of CTX-M beta-lactamase-producing CH5183284 ic50 Escherichia coli and Klebsiella pneumoniae strains in a Tunisian hospital. J Clin Microbiol 2006, 44:4049–4056.PubMedCrossRef 17. Lee MY, Ko KS, Kang CI, Chung DR, Peck KR: High prevalence of CTX-M-15-producing Klebsiella pneumoniae isolates in Asian countries: diverse clones and clonal dissemination. Int J Antimicrob Agents 2011, 38:160–163.PubMedCrossRef 18. Eckert C, Gautier V, Saladin-Allard M, Hidri N, Verdet C: Dissemination of CTX-M-type beta-lactamases among clinical

isolates of Enterobacteriaceae in Paris, France. Antimicrob Agents Chemother 2004, 48:1249–1255.PubMedCrossRef 19. Randrianirina F, Soares JL, Carod JF, Ratsima E, Thonnier V: Antimicrobial resistance among uropathogens that cause community-acquired urinary tract BMS-907351 clinical trial infections in Antananarivo, Madagascar. J Antimicrob Chemother 2007, 59:309–312.PubMedCrossRef 20. Randrianirina F, Vedy S, Rakotovao D, Ramarokoto CE, Ratsitohaina H: Role of contaminated aspiration tubes in nosocomial outbreak of Klebsiella pneumoniae producing SHV-2 and CTX-M-15 extended-spectrum beta-lactamases. J Hosp Infect

2009, 72:23–29.PubMedCrossRef 21. Randrianirina F, Vaillant L, Ramarokoto CE, Rakotoarijaona A, Andriamanarivo ML: Antimicrobial resistance in pathogens causing nosocomial infections in surgery and intensive care units of two hospitals in Antananarivo, Nintedanib (BIBF 1120) Madagascar. J Infect Dev Ctries 2010, 4:74–82.PubMed 22. Andriatahina T, Randrianirina F, Hariniana ER, Talarmin A, Raobijaona H: High prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric unit in Madagascar. BMC Infect Dis 2010, 10:204.PubMedCrossRef 23. Dahmen S, Bettaieb D, Mansour W, Boujaafar N, Bouallegue O: Characterization and molecular epidemiology of extended-spectrum beta-lactamases in clinical isolates of Enterobacteriaceae in a Tunisian University Hospital. Microb Drug Resist 2010, 16:163–170.PubMedCrossRef 24. Robicsek A, Jacoby GA, Hooper DC: The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect Dis 2006, 6:629–640.PubMedCrossRef 25. Robicsek A, Strahilevitz J, Jacoby GA, Macielag M, Abbanat D: Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase.